US Supreme Court rejects ruling banning abortion pill

22 Apr 2023 • 7:30 PM MYT
The Vibes
The Vibes

Featuring breaking news & latest stories from every side.

image is not available
US Supreme Court rejects ruling banning abortion pill

WASHINGTON – The conservative-majority US Supreme Court rejected a lower court ruling that imposed a nationwide ban on the abortion drug mifepristone, court documents revealed, reported Sputnik.

Earlier this month, United States district judge Matthew Kacsmaryk suspended the federal licence for mifepristone, which has been on the US market for over 20 years.

The abortion drug was at risk of becoming an unapproved drug if the Supreme Court did not act within a seven-day window that a judge in Texas granted to appeal the ruling. However, the Supreme Court decided to give itself extra time to study the case.

A US federal judge from the state of Washington had issued a ruling in early April to prohibit the Food and Drug Administration (FDA) from changing the status quo with respect to mifepristone.

President Joe Biden applauded the decision in a statement after the ruling.

“As a result of the Supreme Court’s stay, mifepristone remains available and approved for safe and effective use while we continue this fight in the courts. 

I continue to stand by FDA’s evidence-based approval of mifepristone, and my administration will continue to defend FDA’s independent expert authority to review, approve, and regulate a wide range of prescription drugs,” Biden said yesterday.

Biden also called on the American people to elect a Congress that will pass a law restoring the protections under Roe v Wade. – Bernama, April 22, 2023

Newswav Malaysia Best News App

Newswav is an online content aggregator and obtains its content from different online sources. The content in the app do not belong to Newswav nor do they reflect the opinions of Newswav and its staff. Your use of this app indicates your understanding and acceptance of this information.

Newswav Sdn. Bhd. (201701008480 (1222645-M)) 2026 All Rights Reserved